当前位置:首页 - 行情中心 - 正海生物(300653) - 财务分析 - 利润表

正海生物

(300653)

72.68

-1.71  (-2.30%)

今开:74.53最高:75.49成交:3.51万手 市盈:0.00 上证指数:2875.81   -1.37%2018-06-21
昨收:74.39 最低:71.00 换手:0.00%振幅:0.00 深证指数:9316.68  -1.94%15:02:03

集合

竞价

利润表

按照会计年度查询:
报告期2018-03-312017-12-312017-09-302017-06-30
一、营业总收入47,179,561.64182,782,114.4132,216,381.9784,090,193.22
营业收入47,179,561.64182,782,114.4132,216,381.9784,090,193.22
二、营业总成本25,428,114.29123,117,332.1189,992,775.7561,160,221.15
营业成本3,442,338.4311,561,961.827,746,195.715,192,247.72
营业税金及附加422,722.991,346,747.84988,922.32644,132.94
销售费用15,591,137.8776,303,290.9657,346,358.9336,257,902.39
管理费用6,234,017.4835,893,892.3827,870,044.3620,481,003.6
财务费用-230,441.67-2,128,496.78-4,196,858.23-1,546,090.01
资产减值损失-31,660.81139,935.89238,112.66131,024.51
三、其他经营收益--------
允许价值变动净收益--------
投资净收益3,666,202.726,199,926.79----
联营、合营企业投资收益--------
汇兑净收益--------
四、营业利润25,900,215.0970,604,772.8442,223,606.2222,929,972.07
营业外收入4,2001,447,2702,890,697.911,488,439.81
营业外支出85,061.9965,193.2142,453.4234,442.06
非流动资产处置净损失----15,453.427,442.06
五、利润总额25,819,353.171,986,849.6345,071,850.7124,383,969.82
所得税3,936,430.3810,317,295.526,419,541.733,496,547.66
未确认的投资损失--------
六、净利润(百万元)21.8861.6738.6520.89
少数股东损益--------
归属于母公司股东的净利润21,882,922.7261,669,554.1138,652,308.9820,887,422.16
七、每股收益0.270.860.560.33
基本每股收益0.270.860.560.33
稀释每股收益0.270.860.560.33
TOP↑